» Articles » PMID: 38243275

Multimodal Diagnosis Model of Alzheimer's Disease Based on Improved Transformer

Overview
Publisher Biomed Central
Date 2024 Jan 19
PMID 38243275
Authors
Affiliations
Soon will be listed here.
Abstract

Purpose: Recent technological advancements in data acquisition tools allowed neuroscientists to acquire different modality data to diagnosis Alzheimer's disease (AD). However, how to fuse these enormous amount different modality data to improve recognizing rate and find significance brain regions is still challenging.

Methods: The algorithm used multimodal medical images [structural magnetic resonance imaging (sMRI) and positron emission tomography (PET)] as experimental data. Deep feature representations of sMRI and PET images are extracted by 3D convolution neural network (3DCNN). An improved Transformer is then used to progressively learn global correlation information among features. Finally, the information from different modalities is fused for identification. A model-based visualization method is used to explain the decisions of the model and identify brain regions related to AD.

Results: The model attained a noteworthy classification accuracy of 98.1% for Alzheimer's disease (AD) using the Alzheimer's Disease Neuroimaging Initiative (ADNI) dataset. Upon examining the visualization results, distinct brain regions associated with AD diagnosis were observed across different image modalities. Notably, the left parahippocampal region emerged consistently as a prominent and significant brain area.

Conclusions: A large number of comparative experiments have been carried out for the model, and the experimental results verify the reliability of the model. In addition, the model adopts a visualization analysis method based on the characteristics of the model, which improves the interpretability of the model. Some disease-related brain regions were found in the visualization results, which provides reliable information for AD clinical research.

Citing Articles

An experimental framework for conjoint measures of olfaction, navigation, and motion as pre-clinical biomarkers of Alzheimer's disease.

Biljman K, Gozes I, Lam J, Li V J Alzheimers Dis Rep. 2025; 8(1):1722-1744.

PMID: 40034341 PMC: 11863766. DOI: 10.1177/25424823241307617.


A Feature-Fusion Technique-Based Alzheimer's Disease Classification Using Magnetic Resonance Imaging.

Sait A, Nagaraj R Diagnostics (Basel). 2024; 14(21).

PMID: 39518331 PMC: 11545033. DOI: 10.3390/diagnostics14212363.

References
1.
Shen D, Davatzikos C . HAMMER: hierarchical attribute matching mechanism for elastic registration. IEEE Trans Med Imaging. 2003; 21(11):1421-39. DOI: 10.1109/TMI.2002.803111. View

2.
Brooks D, Pavese N . Imaging biomarkers in Parkinson's disease. Prog Neurobiol. 2011; 95(4):614-28. DOI: 10.1016/j.pneurobio.2011.08.009. View

3.
Tang Y, Liu B, Yang Y, Wang C, Meng L, Tang B . Identifying mild-moderate Parkinson's disease using whole-brain functional connectivity. Clin Neurophysiol. 2018; 129(12):2507-2516. DOI: 10.1016/j.clinph.2018.09.006. View

4.
Frisoni G, Fox N, Jack Jr C, Scheltens P, Thompson P . The clinical use of structural MRI in Alzheimer disease. Nat Rev Neurol. 2010; 6(2):67-77. PMC: 2938772. DOI: 10.1038/nrneurol.2009.215. View

5.
Ferreira L, Busatto G . Neuroimaging in Alzheimer's disease: current role in clinical practice and potential future applications. Clinics (Sao Paulo). 2011; 66 Suppl 1:19-24. PMC: 3118433. DOI: 10.1590/s1807-59322011001300003. View